QCIG
HQL

Quad-Cities Investment Group’s abrdn Life Sciences Investors HQL Stock Holding History

Quad-Cities Investment Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,144
Closed -$144K – 183
2023
Q4 		$144K Hold
10,144
– – 0.09% 165
2023
Q3 		$127K Buy
+10,144
New +$133K 0.08% 170
2023
Q2 		– Sell
-10,137
Closed -$141K – 182
2023
Q1 		$141K Sell
10,137
-540
-5% -$7.72K 0.1% 161
2022
Q4 		$152K Buy
10,677
+220
+2% +$3.19K 0.11% 163
2022
Q3 		$143K Sell
10,457
-431
-4% -$6.44K 0.11% 157
2022
Q2 		$155K Buy
10,888
+267
+3% +$4.03K 0.12% 162
2022
Q1 		$176K Buy
10,621
+33
+0.3% +$568 0.11% 172
2021
Q4 		$204K Buy
10,588
+286
+3% +$5.75K 0.13% 173
2021
Q3 		$214K Buy
10,302
+56
+0.5% +$1.2K 0.15% 153
2021
Q2 		$220K Sell
10,246
-955
-9% -$19.3K 0.15% 156
2021
Q1 		$221K Buy
+11,201
New +$231K 0.17% 142
2020
Q4 		– Sell
-10,745
Closed -$189K – 170
2020
Q3 		$189K Buy
10,745
+2
+0% +$36 0.18% 129
2020
Q2 		$193K Buy
10,743
+196
+2% +$3.36K 0.2% 132
2020
Q1 		$158K Buy
10,547
+319
+3% +$5.22K 0.2% 119
2019
Q4 		$179K Buy
10,228
+184
+2% +$3.02K 0.17% 146
2019
Q3 		$151K Sell
10,044
-867
-8% -$13.9K 0.13% 169
2019
Q2 		$185K Buy
10,911
+234
+2% +$3.85K 0.16% 139
2019
Q1 		$182K Sell
10,677
-64
-0.6% -$1.1K 0.17% 133
2018
Q4 		$162K Buy
10,741
+259
+2% +$4.56K 0.17% 129
2018
Q3 		$215K Buy
10,482
+223
+2% +$4.44K 0.19% 117
2018
Q2 		$193K Sell
10,259
-1,812
-15% -$34.1K 0.18% 126
2018
Q1 		$233K Buy
+12,071
New +$242K 0.3% 108

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Quad-Cities Investment Group's HQL Position: Q1 2024 in Review

Quad-Cities Investment Group sold out of abrdn Life Sciences Investors (HQL) in Q1 2024, closing a stake of 10,144 shares — an estimated $144K sold.

Quad-Cities Investment Group first reported a position in HQL in Q1 2018 and held it in 22 quarters. The position peaked at $233K in Q1 2018. 79 funds tracked by Wall St. Rank hold HQL as of Q1 2024.

  • Quad-Cities Investment Group reported no remaining abrdn Life Sciences Investors position as of Q1 2024 after selling out during the quarter.
  • Quad-Cities Investment Group sold 10,144 abrdn Life Sciences Investors shares in Q1 2024, an estimated $144K.
  • Quad-Cities Investment Group first reported a position in abrdn Life Sciences Investors in Q1 2018 and held it in 22 quarters.
  • Quad-Cities Investment Group's abrdn Life Sciences Investors position peaked at $233K in Q1 2018.
  • 79 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2024.

Based on Quad-Cities Investment Group's 13F filing for Q1 2024, filed 12 Apr 2024.